ROR2 receptor promotes the migration of osteosarcoma cells in response to Wnt5a
Open Access
- 29 November 2017
- journal article
- research article
- Published by Springer Nature in Cancer Cell International
- Vol. 17 (1) , 112
Abstract
We have reported that the phosphatidylinositol-3 kinase (PI3K)/Akt/RhoA signaling pathway mediates Wnt5a-induced cell migration of osteosarcoma cells. However, the specific receptors responding to Wnt5a ligand remain poorly defined in osteosarcoma metastasis. Wound healing assays were used to measure the migration rate of osteosarcoma cells transfected with shRNA or siRNA specific against ROR2 or indicated constructs. We evaluated the RhoA activation in osteosarcoma MG-63 and U2OS cells with RhoA activation assay. A panel of inhibitors of PI3K and Akt treated osteosarcoma cells and blocked kinase activity. Western blotting assays were employed to measure the expression and activation of Akt. Clonogenic assays were used to measure the cell proliferation of ROR2-knockdown or ROR2-overexpressed osteosarcoma cells. Wnt5a-induced osteosarcoma cell migration was largely abolished by shRNA or siRNA specific against ROR2. Overexpression of RhoA-CA (GFP-RhoA-V14) was able to rescue the Wnt5a-induced cell migration blocked by ROR2 knockdown. The Wnt5a-induced activation of RhoA was mostly blocked by ROR2 knockdown, and elevated by ROR2 overexpression, respectively. Furthermore, we found that Wnt5a-induced cell migration was significantly retarded by RhoA-siRNA transfection or pretreatment of HS-173 (PI3Kα inhibitor), MK-2206 (Akt inhibitor), A-674563 (Akt1 inhibitor), or CCT128930 (Akt2 inhibitor). The activation of Akt was upregulated or downregulated by transfected with ROR2-Flag or ROR2-siRNA, respectively. Lastly, Wnt5a/ROR2 signaling does not alter the cell proliferation of MG-63 osteosarcoma cells. Taken together, we demonstrate that ROR2 receptor responding to Wnt5a ligand activates PI3K/Akt/RhoA signaling and promotes the migration of osteosarcoma cells.Keywords
Funding Information
- Jiangsu Provincial Commission of Health and Family Planning (Z201614)
- Jiangsu Province's 333 research project (BRA2016208)
- the Science and Technology Bureau of Changzhou (CJ20130029)
This publication has 38 references indexed in Scilit:
- Dvl2-Dependent Activation of Daam1 and RhoA Regulates Wnt5a-Induced Breast Cancer Cell MigrationPLOS ONE, 2012
- ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumourThe Journal of Pathology, 2012
- The Wnt5a/Ror2 noncanonical signaling pathway inhibits canonical Wnt signaling in K562 cellsInternational Journal of Molecular Medicine, 2010
- Wnt5a regulates distinct signalling pathways by binding to Frizzled2The EMBO Journal, 2009
- The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanomaOncogene, 2009
- Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signalingOncogene, 2009
- Orphan receptor tyrosine kinase ROR2 as a potential therapeutic target for osteosarcomaCancer Science, 2009
- Ror2, a developmentally regulated kinase, promotes tumor growth potential in renal cell carcinomaOncogene, 2009
- Ratio of Wnt3a to BMP4 doses is critical to their synergistic effects on proliferation of differentiating mouse embryonic stem cellsCell Proliferation, 2008
- Purified Wnt5a Protein Activates or Inhibits β-Catenin–TCF Signaling Depending on Receptor ContextPLOS Biology, 2006